Clinical usefulness of biomarkers for diagnosis and prediction of prognosis in sepsis and septic shock. Issue 48 (2nd December 2022)

• Record Type: Journal Article
• Authors: Lee, Jae Ha; Kim, Seong-Ho; Jang, Ji Hoon; Park, Jin Han; Jo, Kyung Min; No, Tae-Hoon; Jang, Hang-Jea; Lee, Hyun-Kyung
• Is Part Of: Medicine. Volume 101:Issue 48(2022)
• Page Start: e31895
• Publication Date: 2022-12-02
• Subjects: biomarkers -- procalcitonin -- prognosis -- sepsis -- septic shock; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000031895
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract : Sepsis is a life-threatening condition and remains a major cause of mortality. The aim of this study was to evaluate the role of biomarkers in the diagnosis of sepsis and septic shock in patients admitted to the emergency department (ED). Medical records of patients who underwent measurement of serum biomarkers including lactic acid, C-reactive protein, procalcitonin (PCT), and presepsin in the ED between May 2019 and May 2020 were retrospectively reviewed. Patients were subdivided into 3 groups; non-sepsis, sepsis, and septic shock according to the new definition using the sequential organ failure assessment score. The mean age was 69.3 years, and 55.8% of the study population was female. Of 249 subjects, 98 patients confined to sepsis group, and 35.7% of them were septic shock. In the multivariable analysis, a high level of PCT was an independent predictor of sepsis (odds ratio [OR], 1.028; 95% confidence interval [CI], 1.006–1.051; P = .011) along with a simplified acute physiology score III (SAPS III) (OR, 1.082; 95% CI, 1.062–1.103, P < .001). PCT was also an independent risk factor for septic shock (OR, 1.043; 95% CI, 1.016–1.071, P = .02). In the receiver operating characteristic curve analysis, the area under the curve of PCT to predict sepsis and septic shock were 0.691 ( P < .001) and 0.734 ( P < .001), respectively. The overall 30-days mortality rate was 8.8%, and the mortality rate was significantly higher in the sepsis group (sepsis vs non-sepsis, 15.3% vs 4.6%; P = .004). In the multivariate Cox analysis, a higher level of lactic acid (hazard ratio [HR], 1.328; 95% CI, 1.061–1.663, P = .013), predisposing chronic pulmonary diseases (HR, 7.035; 95% CI, 1.687–29.341, P = .007), and a high SAPSIII value (HR, 1.046; 95% CI, 1.015–1.078, P = .003) were independent risk factors for mortality in sepsis patients. PCT was a useful biomarker for predicting sepsis and septic shock in the ED. A higher level of lactic acid, predisposing chronic pulmonary diseases, and a high SAPS III score were associated with a greater mortality risk in patients with sepsis.